Phathom Pharmaceuticals Inc (PHAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.41 +0.19 (+4.50%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.45 +0.04 (+0.91%) 18:25 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PHAT | PVLA | TKNO | ||
| Company | Phathom Pharmaceuticals Inc | Palvella Therapeutics Inc | Alpha Teknova Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.24 | 27.18 | 5.28 | ||
| High | 4.48 | 28.00 | 5.62 | ||
| Low | 4.07 | 26.14 | 5.24 | ||
| Last | 4.41 | 27.47 | 5.58 | ||
| Change | +0.19 | +0.28 | +0.38 | ||
| % Change | +4.50% | +1.05% | +7.31% | ||
| Volume | 1,241,700 | 37,000 | 146,700 | ||
| 20-Day Average Volume | 1,218,375 | 55,570 | 515,595 | ||
| Previous Close | 4.22 | 27.18 | 5.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.36 | 22.20 | 6.54 | ||
| 20-Day Raw Stochastic | 11.68% | 84.91% | 13.21% | ||
| 20-Day Relative Strength | 37.72% | 73.93% | 37.51% | ||
| Weighted Alpha | -45.61 | +22.08 | -21.89 | ||
| Today's Opinion | 100% Sell | 100% Buy | 8% Sell | ||
| Previous Opinion | 100% Sell | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 24% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.85% since 03/07/25 | +11.87% since 03/07/25 | -8.37% since 03/07/25 | ||
| Low | 4.07 on 03/14/25 | 22.75 on 03/10/25 | 5.09 on 03/13/25 | ||
| High | 5.25 on 03/12/25 | 29.27 on 03/13/25 | 6.62 on 03/10/25 | ||
| 1-Month | |||||
| %Chg | -23.57% since 02/14/25 | +40.49% since 02/14/25 | -32.61% since 02/14/25 | ||
| Low | 4.07 on 03/14/25 | 17.31 on 02/20/25 | 5.09 on 03/13/25 | ||
| High | 6.98 on 03/06/25 | 29.27 on 03/13/25 | 8.65 on 02/18/25 | ||
| 3-Month | |||||
| %Chg | -44.11% since 12/13/24 | +101.95% since 12/13/24 | -30.51% since 12/13/24 | ||
| Low | 4.07 on 03/14/25 | 11.17 on 12/30/24 | 5.09 on 03/13/25 | ||
| High | 8.60 on 12/18/24 | 29.27 on 03/13/25 | 10.37 on 01/27/25 | ||
| 6-Month | |||||
| %Chg | -75.90% since 09/13/24 | +64.76% since 09/13/24 | +26.82% since 09/13/24 | ||
| Low | 4.07 on 03/14/25 | 11.17 on 12/30/24 | 4.15 on 09/16/24 | ||
| High | 19.71 on 09/19/24 | 29.27 on 03/13/25 | 10.37 on 01/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 307,099 | 308,185 | 298,178 | ||
| Shares Outstanding, K | 69,637 | 11,221 | 53,437 | ||
| Annual Sales | 55,250,000 | 42,810,000 | 37,750,000 | ||
| Annual Net Income | -334,330,000 | -24,540,000 | -26,750,000 | ||
| Last Quarter Sales | 29,660,000 | 0 | 9,270,000 | ||
| Last Quarter Net Income | -74,450,000 | -3,590,000 | -5,720,000 | ||
| 60-Month Beta | 0.63 | 0.54 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.79 on 03/06/25 | -2.19 on 11/13/24 | -0.11 on 03/04/25 | ||
| Latest Earnings Date | 05/08/25 | 04/04/25 | 03/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||